Evidence map›Paper›PMID 31817123›Full record

ArticleDiagnostics (Basel, Switzerland)2019

The Effect of Zoledronic Acid on Serum Biomarkers among Patients with Chronic Low Back Pain and Modic Changes in Lumbar Magnetic Resonance Imaging.

Katri Koivisto, Jaro Karppinen, Marianne Haapea, Jyri Järvinen, Eero Kyllönen, Osmo Tervonen, Jaakko Niinimäki, Mauro Alini, Jeffrey Lotz, Stefan Dudli and 5 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Characterization of microenvironmental changes in the intervertebral discs of patients with chronic low back pain using multiparametric MRI contrasts extracted from Z-spectrum.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Katri KoivistoMedical Research Center Oulu, Oulu University Hospital and University of Oulu, 90220 Oulu, Finland.
Jaro KarppinenMedical Research Center Oulu, Oulu University Hospital and University of Oulu, 90220 Oulu, Finland.
Marianne HaapeaMedical Research Center Oulu, Oulu University Hospital and University of Oulu, 90220 Oulu, Finland.
Jyri JärvinenMedical Research Center Oulu, Oulu University Hospital and University of Oulu, 90220 Oulu, Finland.
Eero KyllönenMedical Research Center Oulu, Oulu University Hospital and University of Oulu, 90220 Oulu, Finland.
Osmo TervonenResearch Unit of Medical Imaging, Physics and Technology, University of Oulu, 90220 Oulu, Finland.
Jaakko NiinimäkiResearch Unit of Medical Imaging, Physics and Technology, University of Oulu, 90220 Oulu, Finland.
Mauro AliniAO Research Institute Davos, 7270 Davos Platz, Switzerland.
Jeffrey LotzDepartment of Orthopaedic Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Stefan DudliCenter of Experimental Rheumatology, University Hospital Zurich, 8008 Zurich, Switzerland.
Dino SamartzisDepartment of Orthopedic Surgery, RUSH University, Chicago, Il 60612, USA.
Juha RisteliNorthern Finland Laboratory Centre NordLab, Oulu University Hospital, 90220 Oulu, Finland.
Marja-Leena MajuriMedical Research Center Oulu, Oulu University Hospital and University of Oulu, 90220 Oulu, Finland.
Harri AleniusInstitute of Environmental Medicine, Karolinska Institute, 17177 Stockholm, Sweden.
Sibylle GradAO Research Institute Davos, 7270 Davos Platz, Switzerland.

Funding

Hansjörg Wyss Research Award (AOSpine) ---Novartis Pharma 0
6 · The paper itself

Abstract

The aim of the current study was to compare changes in serum biomarkers, including inflammatory mediators, signaling molecules, growth factors and markers of bone turnover after a single intravenous infusion of 5 mg zoledronic acid (ZA, a long-acting bisphosphonate;

Indexed as

chronic low back painmagnetic resonance imagingModic changerandomized trialserum biomarkerszoledronic acid

Identifiers

PMID31817123
PMCPMC6963270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.